Maidment, Ian

Impact of Anticholinergics on the Aging Brain: A Review and Practical Application

Boustani, M., Campbell, N., Munger, S., Maidment, I., & Fox, C. (2008) · Aging Health

Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research

Cited by 862

Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study

Fox, C., Richardson, K., Maidment, I. D., Savva, G. M., Matthews, F. E., Smithard, D., Coulton, S., Katona, C., Boustani, M. A., & Brayne, C. (2011) · Journal of the American Geriatrics Society

Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research

Cited by 655

Anticholinergic drugs and risk of dementia: case-control study

Richardson, K., Fox, C., Maidment, I., Steel, N., Loke, Y. K., Arthur, A., Myint, P. K., Grossi, C. M., Mattishent, K., Bennett, K., et al. (2018) · BMJ

Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research

Cited by 520

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease

Rolinski, M., Fox, C., Maidment, I., & McShane, R. (2012) · Cochrane Database of Systematic Reviews

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 418

Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial

Fox, C., Crugel, M., Maidment, I., Auestad, B. H., Coulton, S., Treloar, A., Ballard, C., Boustani, M., Katona, C., & Livingston, G. (2012) · PLoS ONE

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 173

Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis

Pieper, N. T., Grossi, C. M., Chan, W.-Y., Loke, Y. K., Savva, G. M., Haroulis, C., Steel, N., Fox, C., Maidment, I. D., Arthur, A. J., et al. (2020) · Age and Ageing

Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research

Cited by 138

Medication usage change in older people (65+) in England over 20 years: findings from CFAS I and CFAS II

Gao, L., Maidment, I., Matthews, F. E., Robinson, L., Brayne, C., & on behalf of the Medical Research Council Cognitive Function and Ageing Study (2018) · Age and Ageing

Pharmaceutical Practices and Patient OutcomesChronic Disease Management Strategies

Cited by 123

Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study

Richardson, K., Loke, Y. K., Fox, C., Maidment, I., Howard, R., Steel, N., Arthur, A., Boyd, P. J., Aldus, C., Ballard, C., et al. (2020) · BMC Medicine

Pharmaceutical Practices and Patient OutcomesSleep and related disorders

Cited by 73

History of benzodiazepine prescriptions and risk of dementia: possible bias due to prevalent users and covariate measurement timing in a nested case-control study

Richardson, K., Mattishent, K., Loke, Y. K., Steel, N., Fox, C., Grossi, C. M., Bennett, K., Maidment, I., Boustani, M., Matthews, F. E., et al. (2019) · American Journal of Epidemiology

Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research

Cited by 36